Delivery Order SPE2DB22D1106-SPE2DB24FEYH3

Award Date 6/22/24
Potential Completion Date 6/24/24
Potential Value $5.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $2,528.41 firm fixed price delivery order is for the supply of 4564094917 - Potassium Phosphate 45 MMOL/15 ML 15ML, with a performance period through March 28, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564510545 - POTASSIUM PHOSP 45 MMOL/15 ML 15ML. The contract has a firm fixed price of $3,298.48 and a completion date of May 7, 2024. The award was made by the Defense Logistics Agency (DLA), a defense agency, without the use of a set-aside. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department...
This federal contract award, valued at $2,149.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,142,826 potassium chloride extended-release tablets, 500 tablets per bottle. The contract is not set aside and has an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $3,890.35 to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4563634627 - POTASSIUM CL ER 20 MEQ TABLET 500S, with a completion date of February 13, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, including the Department of...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,595.79, is for the delivery of Potassium Phosphate 45 mmol/15 ml (15 ml) to support federal government healthcare requirements. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This...
This is a $1,668.94 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of potassium chloride, a medical product, with a period of performance ending on May 22, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a pharmaceutical product - Potassium Cl 10% (20meq/15ml) Cup UD 15ml. The $1,137.68 contract has a completion date of January 23, 2024 and was awarded on January 22, 2024. Amerisourcebergen Drug Corp is a For Profit Organization that provides pharmaceutical products and services to U.S. government agencies, primarily the Department...
This federal contract award is for the delivery of 4,566,405,585 potassium chloride extended-release (ER) 8 milliequivalent (meq) tablets in 500-count packages. The contract, valued at $1,823.68, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 45 millimole/15 milliliter (mmol/15 mL) sodium phosphate solution. The $3,827.12 contract has a completion date of February 14, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,535.67, is for the supply of POTASSIUM CL 20 MEQ PACKET 100S medical packets. The contract has an ultimate completion date of October 9, 2024 and is a firm fixed-price delivery order. This contract is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FEYH3
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,978,599 units of Potassium Phosphate 45 mmol/15 ml, 15 ml. The contract has a ceiling value of $5,093.73 and an ultimate completion date of June 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific order was not set aside for any small business or socioeconomic program.

Generated 9/22/24, 12:47 AM